What is Retatrutide / Cagrilintide?
The first component, retatrutide, is a synthetic incretin family peptide listed in the molecular reference for this catalog under CAS 2381089-83-2 with the formula C256H392N64O79 and an average mass of 4731.2. Preclinical reports describe it as a single chain agonist at the GLP-1, GIP, and glucagon receptors.
The second component, cagrilintide, is an acylated analogue of amylin, a pancreatic hormone peptide that signals through calcitonin and amylin receptor complexes. The molecular reference carries no CAS number, formula, mass, or sequence for the blend, so no combined chemistry values are quoted; component chemistry is read from the individual entries instead.
The pairing appears in the literature for structural reasons. Amylin pathway and incretin pathway signalling converge on overlapping hindbrain circuits in rodent models, and combining them lets investigators separate additive from redundant effects in one experiment. What is not settled is whether either component alters the aggregation behaviour of the other in solution, and how the blend compares with the two peptides supplied separately in the same model system. Both are acylated, so the blend is treated as two distinct analytes in quantitative work.
Reconstitution & handling
Diluent is added slowly against the vial wall and the vial is rolled rather than shaken, since two acylated peptides in one solution foam readily. Concentration arithmetic applies to each labelled component separately, so a vial marked 10 mg and 5 mg reconstituted with 2 mL yields 5 mg per millilitre of the first component and 2.5 mg per millilitre of the second.
Storage & stability
Sealed vials are stored at -20 °C away from light and moisture and warmed to room temperature before opening. Reconstituted blend is refrigerated at 2 to 8 °C, aliquoted into single use portions, and protected from repeated freezing and thawing, a particular risk here because the two components do not necessarily aggregate at the same rate. Low binding vials are preferred, as both acylated species adsorb onto untreated plastic.
How it's tested
Blend lots are analysed by reversed phase HPLC at 214 and 220 nm, where the two components resolve as separate peaks, and both peak areas are reported. Mass spectrometry confirms each component against its own theoretical mass rather than a single combined figure. Net peptide content is reported per component, and the lot-matched certificate showing the ratio is available on request.